Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUltrasis Plc Regulatory News (ULT)

  • There is currently no data for ULT

Re Contract

20 Feb 2008 08:02

Ultrasis PLC20 February 2008 Press release 20th February 2008 Ultrasis plc East of England Primary Care Trusts Commission Beating the Blues Ultrasis plc, the provider of interactive healthcare and associated services, ispleased to announce that the 7 Primary Care Trusts ("PCTs") in the East ofEngland Strategic Health Authority (SHA) have committed to provide Beating theBlues ("BtB") to all patients suffering from mild to moderate depression. The 7PCT's will have a contract value in excess of £420,000 over a two year period. Afurther 3 PCT's have indicated their willingness to purchase but are awaitingconfirmation of their 2008/09 funding allocation. Ultrasis recently announced the wide scale adoption of Beating the Blues byPCT's in the North East Strategic Health Authority, following the lead of EastMidlands in August 2007. The deadline for all PCT's to be compliant withGovernment Policy on making this evidence based treatment for depressionavailable is the 31st March 2008. Nigel Brabbins, Chief Executive at Ultrasis, said: "This is fantastic news forUltrasis and even better news for the people who live in the catchment areas ofthese Primary Care Trusts. The evidence is clear that treating depression withBeating the Blues is far more cost effective than face to face treatment and hasthe added benefit of there being no waiting time to receive it. "Using the internet is becoming an increasingly popular way for people to managetheir busy lives and now they can manage their mental health and wellbeing inthe same way by using this proven computer based treatment program." - ends - For further information please contact: Ultrasis plc:Nigel Brabbins, Chief Executive +44 (0) 20 7566 3900nbrabbins@ultrasis.com www.ultrasis.com JMFinn Capital Markets Ltd, NOMAD and Joint Broker Geoff Nash +44 (0) 20 7600 1658 Media enquiries: Capital MS&LJames Madsen +44 (0) 20 7307 5330james.madsen@capitalmsl.com Notes to editors: About Ultrasis plc Cognitive Behavioural therapy (CBT) is the psychological treatment of choice forpeople suffering from anxiety and depression, but the cost of a course of faceto face treatment (£750) and the shortage of therapists has seriously hamperedprovision, with waiting times in some areas stretching up to two years. NICEclinical guidelines for depression and anxiety (published in Dec 2004)emphasised the importance of this therapy and at the same time recommended thatsufferers from mild depression should not, initially, be given drugs andself-help material, preferably based on CBT, should be offered. Beating the Blues is an eight-week, web-based treatment programme for depressionbased on Cognitive Behavioural Therapy. Following a rigorous examination by theNational Institute for Health and Clinical Excellence (NICE), "Beating the Blues" was approved by NICE in February 2006 with a requirement that it be madeavailable across the NHS as an option for all people with mild and moderatedepression. Guidance arising from NICE Health Technology Assessments is binding on the NHSand, based on undertakings from ministers, implementation of guidance wasexpected to be funded within twelve months of publication. However, this timetable to implement was in effect extended by another year to2007/8, when the Rt Hon Patricia Hewitt, then the Secretary of State for Health,at the MIND conference in March 2007 speaking approvingly of "Beating the Blues", said: "Computer-based therapy for milder, but more common mental healthconditions such as depression and anxiety should be made available to anypatients in England who could benefit from it from April 2007," a deadline ofdays, impossible to achieve. This commitment was reiterated in the Comprehensive Spending Review (CSR) ofNovember 2007, when the Rt Hon Alan Johnson MP, the new Secretary of State forHealth, announced the provision of another £170m for the Improving Access toPsychological Therapies programme. In defiance of declared government policy PCTs prove persistently slow toimplement. The ineffective response of senior staff in the DH and ministers isto advise patients to complain. We do receive a steady and growing stream ofinquiries from members of the public asking why their GPs are not able toprovide BtB. Ultimately over 3 million people per year should benefit fromBeating the Blues(R) at costs a fraction of those for providing face to facetherapy or antidepressants Beating the Blues(R), unlike many of the existing methods used to provide 'talking therapies', does not require years of expensive therapist trainingbefore it can be deployed to patients, is available at times that suit thepatients' needs , can be increased in volume to meet demand and is based on theprinciple of individual empowerment, enabling people to take more control oftheir own health profile, reducing long term dependency on health systems. Seven out of Ten patients suffering from depression who used Beating the Blues(R) required no further treatment. Waiting lists for face to face therapy extendto 18 months in some areas. Deployment of Beating the Blues(R) will cut these toa matter of days and help deliver another of the government's major commitments,the 18 week pathway. Ultrasis was the first company to offer computerised products based on CognitiveBehavioural Therapy (CBT) and interactive multimedia, and is the world leader inthe field. The products help people tackle stress, anxiety and depression, and afull spectrum of related chronic conditions. www.ultrasis.comwww.thewellnessshop.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th May 20069:59 amRNSEPT Disclosure - Ultrasis plc
10th May 20068:34 amRNSEPT Disclosure - Ultrasis plc
9th May 20068:53 amRNSEPT Disclosure - Ultrasis plc
3rd May 20068:34 amRNSEPT Disclosure - Ultrasis plc
2nd May 200611:00 amRNSEPT Disclosure - Ultrasis plc
28th Apr 20063:02 pmRNSEPT Disclosure - Amendment
28th Apr 200610:07 amRNSEPT Disclosure - Ultrasis plc
27th Apr 20065:38 pmRNSResult of Meeting
27th Apr 20069:29 amRNSEPT Disclosure - Ultrasis plc
27th Apr 20067:02 amRNSDepartment of Health talks
26th Apr 20065:40 pmRNSEPT Disclosure - Amendment
26th Apr 20068:32 amRNSEPT Disclosure - Ultrasis plc
25th Apr 20069:28 amRNSEPT Disclosure - Ultrasis plc
20th Apr 200610:17 amRNSEPT Disclosure - Ultrasis plc
13th Apr 20069:09 amRNSEPT Disclosure - Ultrasis plc
12th Apr 20068:59 amRNSEPT Disclosure - Ultrasis plc
11th Apr 20068:56 amRNSEPT Disclosure - Ultrasis plc
6th Apr 20069:04 amRNSEPT Disclosure - Ultrasis plc
4th Apr 200610:38 amRNSEPT Disclosure - Ultrasis plc
3rd Apr 20065:21 pmRNSEPT Disclosure - Ultrasis plc
31st Mar 20063:05 pmRNSScheme of arrangement update
31st Mar 200610:36 amRNSEPT Disclosure - Ultrasis plc
29th Mar 200610:49 amRNSEPT Disclosure - Amendment
29th Mar 200610:43 amRNSEPT Disclosure - Amendment
28th Mar 20069:41 amRNSEPT Disclosure - Ultrasis plc
27th Mar 20068:57 amRNSEPT Disclosure - Ultrasis plc
24th Mar 20068:51 amRNSEPT Disclosure
17th Mar 20061:05 pmRNSGrant of Options
16th Mar 20064:58 pmRNSDoc re. Rule 2.6
16th Mar 200611:12 amRNSEPT Disclosure
15th Mar 20068:00 amRNSScheme of arrangement
9th Mar 20064:00 pmRNSIssue of Equity
22nd Feb 20069:54 amRNSNICE Statement
9th Feb 20063:27 pmRNSResult of AGM
23rd Jan 200612:30 pmRNSAdditional Listing
12th Jan 20064:11 pmRNSAGM Statement
9th Jan 20064:17 pmRNSDirector Shareholding
9th Jan 20069:53 amRNSAdditional Listing
28th Nov 200511:44 amRNSContracts
28th Sep 20057:01 amRNSDirectorate Change
9th Sep 200511:05 amRNSFinal Results
9th Sep 200510:50 amRNSDistribution Agreement
10th Aug 200510:39 amRNSRe Contract
15th Jun 20057:00 amRNSAgreement
6th Jun 200510:50 amRNSAdditional Listing
6th Jun 200510:46 amRNSDirector Shareholding
3rd Jun 20057:00 amRNSIssue of Equity
31st May 200510:40 amRNSAppraisal by NICE
23rd May 200510:29 amRNSUS Pilot Programme
11th May 20051:00 pmRNSNew Order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.